{"id":"W4286298426","doi":"10.1200/jco.2022.40.16_suppl.8052","title":"Daratumumab (DARA) in combination with bortezomib plus dexamethasone (D-Vd) or lenalidomide plus dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Subgroup analysis of the phase 3 CASTOR and POLLUX studies in patients (pts) with early or late relapse after initial therapy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Lenalidomide; Daratumumab; Clinical endpoint; Oncology; Dexamethasone; Subgroup analysis; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002912204,0.001014911,0.002272795,0.0005710152,0.0002859227,0.0009899338,0.0006470229,0.0008403374,0.00164117],"category_scores_gemma":[0.002187607,0.0005074515,0.004480857,0.0006841015,0.0005440844,0.0006808788,0.0006543919,0.001531534,0.0002516465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008326295,"about_ca_system_score_gemma":0.001055365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001049049,"about_ca_topic_score_gemma":0.003289999,"domain_scores_codex":[0.9987979,0.0006899665,0.0001078585,0.0001770858,0.00008483406,0.0001423843],"domain_scores_gemma":[0.9989513,0.0003182675,0.000303125,0.0001009692,0.00005179086,0.0002746067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9295509,0.002788516,0.02343694,0.0006740258,0.01199128,0.00008793486,0.0001109606,0.0007036321,0.003062392,0.00008244794,0.0006751768,0.02683567],"study_design_scores_gemma":[0.5541331,0.2916702,0.1211633,0.0002168616,0.02457978,0.0004253669,0.0002479393,0.002047395,0.001929594,0.0004777697,0.003017602,0.00009119916],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939989,0.004372388,0.0001555272,0.0001618017,0.00007829437,0.0004314144,0.0004376434,0.00001426252,0.0003498415],"genre_scores_gemma":[0.9968386,0.00128011,0.0002935022,0.0002472442,0.00009614498,0.0003427428,0.0006129638,0.000005739358,0.0002829653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002912204,"threshold_uncertainty_score":0.01540142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1514878729162573,"score_gpt":0.4575004791665281,"score_spread":0.3060126062502709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}